Veracyte Expands Availability of Decipher Prostate Test
Veracyte has launched Decipher Prostate test, a Medicare-covered test for guiding treatment in metastatic prostate cancer.
Read MorePosted by Chris Wolski | Apr 25, 2025 | Prostate |
Veracyte has launched Decipher Prostate test, a Medicare-covered test for guiding treatment in metastatic prostate cancer.
Read MorePosted by Chris Wolski | Apr 22, 2025 | Cancer |
Liquid biopsy is a groundbreaking, non-invasive method for early cancer detection and monitoring, offering significant clinical potential.
Read MorePosted by Chris Wolski | Apr 21, 2025 | Prostate |
Decipher Prostate Genomic Classifier data is included in a new SEER Program database, enabling the study of prostate cancer outcomes.
Read MorePosted by Andy Lundin | Jan 22, 2025 | Unknown Origin & Other Cancer Types |
A biomarker-based algorithm combined with a noninvasive test identifies those at risk for esophageal cancer or precancerous conditions.
Read MorePosted by Andy Lundin | Jan 9, 2025 | Cancer, Molecular Diagnostics |
Summary: A Mayo Clinic-led international study utilized CRISPR-Cas9 technology to classify 91% of...
Read More